Skip to main content

Table 5 Comparison of Māori compared with non-Māori patients (Stage I-III): receipt of definitive treatment and excess mortality

From: A retrospective cohort study of patients with stomach and liver cancers: the impact of comorbidity and ethnicity on cancer care and outcomes

  Receipt of definitive treatment Cancer-specific All-cause
  OR (95% CI) HR (95% CI) HR (95% CI)
Crude 1.26 (0.79-2.02) 1.03 (0.76-1.4) 1.01 (0.76-1.35)
+ age, sex and site 0.9 (0.51-1.61) 1.28 (0.92-1.76) 1.25 (0.92-1.70)
+ stage 0.9 (0.49-1.63) 1.33 (0.96-1.85) 1.29 (0.95-1.76)
+ comorbidity* 1.07 (0.57-1.99) 1.23 (0.88-1.72) 1.23 (0.89-1.69)
+ treatment receipt - 1.36 (0.97-1.90) 1.33 (0.97-1.82)
+ health service access factors** 1.12 (0.54-2.35) 1.27 (0.88-1.85) 1.21 (0.85-1.72)
  1. *Adjusted for both comorbidity count and C3 index.
  2. **Adjusted for deprivation (NZDep decile) and rurality.